Cvic is the General Partner of Frankenbuild Ventures — or F(v) — a MA-based VC firm investing in companies building hardtech to function in extreme environments. Her professional background blends experiences of being an investment director with her experiences in instrument development of deeptech. As such, she is very well-networked in the prototype-development communities, and the startup ecosystem in Boston and beyond. Having previously worked for NASA (2007-2009), in 2023 she was invited to give a six-seminar series of videos explaining and promoting NASA’s SBIR efforts with engineering founders and in 2024 she was listed as a Woman to Watch in VC by Amplify.

Ahmed Fazly earned his doctoral degree in Biomedical Sciences from the Mayo Clinic College of Medicine in Rochester, MN. He began his postdoctoral journey at the University of Massachusetts Medical School in Worcester, where his research produced promising antifungal drug candidates. After teaching high school chemistry and biology at a Boston charter school, he returned to research as a postdoctoral associate in Biological Engineering at MIT, specializing in RNA modifications. His work at MIT secured STTR funding from the NIH and the Congressionally Directed Medical Research Program of the Department of Defense.

Transitioning into finance, Ahmed became a wall street sell-side analyst specializing in the rare disease therapeutics sector. His entrepreneurial drive was fostered through the Wharton School at the University of Pennsylvania’s VIP program  After contributing to commercial strategy at a biotech company in Cambridge and completing his MBA, he once again embraced entrepreneurship as the co-founder of a startup dedicated to pioneering gene editing therapies for severe genetic diseases lacking effective treatments.